{"protocolSection":{"identificationModule":{"nctId":"NCT05786170","orgStudyIdInfo":{"id":"ERILs und SNILs unter SOC"},"organization":{"fullName":"Medical University of Vienna","class":"OTHER"},"briefTitle":"ERILs Und SNILs Unter SOC","officialTitle":"Early Recurrent Ischemic Lesions (ERILs) and Silent Neurologic Ischemic Lesions (SNILs) in Diffusion-weighted Magnetic Resonance Imaging (DW-MRI) - a Pilot- Observational Study Under Standard of Care (SOC)"},"statusModule":{"statusVerifiedDate":"2023-03","overallStatus":"WITHDRAWN","whyStopped":"lack of research funding","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-09","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2021-07-05","type":"ACTUAL"},"completionDateStruct":{"date":"2021-07-05","type":"ACTUAL"},"studyFirstSubmitDate":"2023-03-14","studyFirstSubmitQcDate":"2023-03-14","studyFirstPostDateStruct":{"date":"2023-03-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-03-14","lastUpdatePostDateStruct":{"date":"2023-03-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Christa Firbas MD","investigatorTitle":"MD","investigatorAffiliation":"Medical University of Vienna"},"leadSponsor":{"name":"Medical University of Vienna","class":"OTHER"},"collaborators":[{"name":"Medical University Innsbruck","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"1. How many ERILs occur in caucasian patients with LAA stroke during 7 days on standard treatment?\n2. How many SNILs occur between 7 and 30 days after acute ischemic event on standard treatment?\n3. How many of during acute event diagnosed lesions (ERILs) are (still) detectable after 30 days?\n4. Are there relevant risk faktors for the occurence of ERILs and SNILs (eg Diabetes or Biomarkers)?","detailedDescription":"In this trial, patients will be observed if they develop early recurrent ischemic lesions (= ERILs) or silent neurologic ischemic lesions (= SNILs) after acute stroke or transitoric ischemic attack (TIA) based on atherothrombosis (LAA-stroke) on standard therapy during 30 days (day 7 and day 30 after acute event) via DW-MRI (diffusion-weighted magnetic resonance imaging).\n\nWe want to investigate if diffusion-weighted imaging of silent brain infarcts occuring during standard therapy is a suitable surrogate outcome measure for interventional studies"},"conditionsModule":{"conditions":["Stroke, Acute"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"DIAGNOSTIC","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":0,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"magnetic resonance imaging","type":"EXPERIMENTAL","description":"DW-MRI after ischemic stroke","interventionNames":["Diagnostic Test: diffusion-weighted magnetic resonance imaging"]}],"interventions":[{"type":"DIAGNOSTIC_TEST","name":"diffusion-weighted magnetic resonance imaging","description":"diffusion-weighted magnetic resonance imaging","armGroupLabels":["magnetic resonance imaging"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"1. How many ERILs occur in caucasian patients with LAA stroke during 7 days on standard treatment?","description":"DW-MRI to detect lesions","timeFrame":"7 days after acute stroke"}],"secondaryOutcomes":[{"measure":"2. How many SNILs occur between 7 and 30 days after acute ischemic event on standard treatment and how many of during acute event diagnosed lesions (ERILs) are (still) detectable after 30 days?","description":"DW-MRI to detect lesions","timeFrame":"30 days after acute stroke"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* LAA stroke or TIA\n* ERILs or SNILs detected in initialDW-MRI\n* signed informed consent\n\nExclusion Criteria:\n\n* planned surgical intervention\n* iv Thrombolysis\n* atrial fibrillation\n* contra indications against DW-MRI","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"100 Years","stdAges":["ADULT","OLDER_ADULT"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke, Acute","relevance":"HIGH"},{"id":"M4804","name":"Body Weight","relevance":"LOW"},{"id":"M14540","name":"Recurrence","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}